Cargando…
Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome
Congenital adrenal hyperplasia (CAH) is a group of autosomally recessive disorders that result from impaired synthesis of glucocorticoid and mineralocorticoid. Most cases (~95%) are caused by mutations in the CYP21A2 gene, which encodes steroid 21-hydroxylase. CAH patients manifest a wide phenotypic...
Autores principales: | Kim, Ja Hye, Kim, Gu-Hwan, Yoo, Han-Wook, Choi, Jin-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Pediatric Endocrinology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329939/ https://www.ncbi.nlm.nih.gov/pubmed/37401054 http://dx.doi.org/10.6065/apem.2346108.054 |
Ejemplares similares
-
Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
por: Paragliola, Rosa Maria, et al.
Publicado: (2022) -
Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras
por: Lao, Qizong, et al.
Publicado: (2021) -
Data on the functional consequences of the mutations identified in 21-Hydroxylase deficient CAH patients
por: Khajuria, Ragini, et al.
Publicado: (2018) -
Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
por: Dörr, Helmuth G., et al.
Publicado: (2018) -
Data on the 21-Hydroxylase deficient CAH patients and the
identification of known/novel mutations in CYP21A2 gene
por: Khajuria, Ragini, et al.
Publicado: (2016)